| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 34,730 | 34,900 | 20:24 | |
| 34,805 | 34,965 | 20:24 |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 41,960 | 100 | |||
| 40,800 | 130 | |||
| 39,360 | 150 | |||
| 39,000 | 5 | |||
| 38,600 | 450 | |||
| 38,300 | 150 | |||
| 37,200 | 165 | |||
| 36,880 | 70 | |||
| 35,035 | 115 | |||
| 34,970 | 1.152 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/qia.htm [/URL] | ||||
| 115 | 34,805 | |||
| 1.152 | 34,760 | |||
| 150 | 34,750 | |||
| 100 | 34,600 | |||
| 246 | 34,500 | |||
| 400 | 34,250 | |||
| 50 | 34,240 | |||
| 900 | 34,000 | |||
| 50 | 33,050 | |||
| 50 | 33,000 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 3.213 | 0,774 | 2.487 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 17:29:56 | 35,000 | 557 |
| 17:29:28 | 34,990 | 74 |
| 17:29:28 | 34,985 | 224 |
| 17:29:00 | 34,995 | 110 |
| 17:27:33 | 35,005 | 39 |
| 17:27:32 | 34,995 | 120 |
| 17:27:32 | 34,990 | 34 |
| 17:27:27 | 34,985 | 390 |
| 17:27:17 | 34,990 | 54 |
| 17:27:16 | 34,995 | 190 |
| 17:27:16 | 34,995 | 55 |
| 17:27:16 | 34,995 | 323 |
| 17:27:16 | 35,005 | 599 |
| 17:26:23 | 34,985 | 42 |
| 17:26:23 | 34,990 | 622 |
| 17:25:55 | 35,005 | 203 |
| 17:25:16 | 34,990 | 124 |
| 17:24:28 | 34,995 | 15 |
| 17:24:28 | 35,010 | 410 |
| 17:24:28 | 35,005 | 86 |
| Tagesumsatz Xetra | -0,610 -1,71 % | 459.374 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | QIAGEN NV - Stabilität als strategische Basis | 24 | Maximilian Berger | ||
| Di | Qiagen erweitert Portfolio um Test für Blutstrominfektionen | 12 | Investing.com Deutsch | ||
| Di | Qiagen launches bloodstream infection testing panel | 6 | Investing.com | ||
| Di | QIAGEN N.V.: QIAGEN Expands Into Bloodstream Infection Syndromic Testing With New Rapid QIAstat-Dx Panel | 373 | Business Wire | QIAstat-Dx BCID GPF Plus AMR Panel detects gram-positive bacteria, fungi and key antimicrobial resistance markers from positive blood cultures and colonies CE-IVDR-certified panel identifies... ► Artikel lesen | |
| QIAGEN Aktie jetzt für 0€ handeln | |||||
| Di | BARCLAYS stuft QIAGEN NV auf 'Equal Weight' | 692 | dpa-AFX-Analyser | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Qiagen von 58 auf 44 Dollar gesenkt, aber die Aktie von "Overweight" auf "Equal Weight" abgestuft. Eine Übernahme... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| 13:26 | Resverlogix Corp.: Resverlogix Corp. Announces Filing of Annual Filings and Revocation of MCTO | Newsfile | Calgary, Alberta--(Newsfile Corp. - April 16, 2026) - Resverlogix Corp. (TSX: RVX) ("Resverlogix" or the "Company") announces the revocation, effective April 15, 2026, of a management cease trade... ► Artikel lesen | |
| 18:06 | Medincell to Host an Online R&D Day on Tuesday, May 12, 2026 | Business Wire | > From Science to Long-Term Value Creation
Regulatory News:
Medincell (Euronext Paris: MEDCL) will host an online R&D Day, held in English, on Tuesday, May 12, 2026, from 4:00 to 5:30 pm CEST... ► Artikel lesen | |
| 13:26 | OS Therapies: OS Therapies Files New Patent Application Covering Biomarkers of the Immune Response to Listeria Monocytogenes | Newsfile | New patent application covers treatment-emergent immune signature related to 'turning cold tumors hot' and the activation of targeted cytotoxic cellular immune responses Company to host conference... ► Artikel lesen | |
| 14:06 | Bio-Techne Corporation: Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity | PR Newswire | Bio-Techne introduces a streamlined brand architecture that organizes its technologies into three focused portfolio brands: R&D Systems, Bio-Techne Spatial, and Bio-Techne Diagnostics.The... ► Artikel lesen | |
| 14:06 | Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026 | PR Newswire | SAN DIEGO and NEW YORK, April 16, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, today announced that the Mount Sinai Health System... ► Artikel lesen |